Breast Cancer

, 16:2

Current status of breast cancer screening in the world

  • Tadaoki Morimoto
  • Taeko Nagao
  • Kenji Okazaki
  • Misako Kira
  • Yasushi Nakagawa
  • Akira Tangoku
Special Feature New trends in breast cancer screening

DOI: 10.1007/s12282-008-0077-5

Cite this article as:
Morimoto, T., Nagao, T., Okazaki, K. et al. Breast Cancer (2009) 16: 2. doi:10.1007/s12282-008-0077-5

Abstract

The mortality associated with breast cancer is decreasing in Europe and the United States. There are various reasons for these trends, including an increase in detection of early-stage breast cancers due to increased use of mammographic screening and the establishment of standardized systemic treatments based on evidence-based medicine. However, in Japanese women, both the morbidity and the mortality of breast cancer are increasing. In this manuscript, we describe the current status of mammographic screening in Europe and the United States, and the status of breast cancer screening in Japan. Quality control systems are also introduced, and the need for practical measures, such as implementation of quality control systems aimed at improving the cancer screening rate (with a target of 50%) and population-based screening (organized screening), based on the Cancer Control Act, is described. Current countermeasures for dense breasts in women in their 40s, both overseas and in Japan, are also described, together with discussions of the diagnostic capability of digital mammography, the usefulness of screening combined with computer-aided diagnosis, and the current status of screening using MRI in Europe and the United States.

Keywords

Breast cancerScreeningMortality reductionMammographyQuality control

Copyright information

© The Japanese Breast Cancer Society 2008

Authors and Affiliations

  • Tadaoki Morimoto
    • 1
  • Taeko Nagao
    • 2
  • Kenji Okazaki
    • 2
  • Misako Kira
    • 2
  • Yasushi Nakagawa
    • 2
  • Akira Tangoku
    • 2
  1. 1.Professor Emeritus of The University of TokushimaTokushimaJapan
  2. 2.Department of Thoracic, Endocrine Surgery and Oncology, Institute of Health BioscienceThe University of Tokushima Graduate SchoolTokushimaJapan